The Diagnostic Value of MTAP Expression as a Surrogate for CDKN2A Deletion in Glioma and Meningioma: A Comprehensive Systematic Review and Meta-analysis (P4-6.005)
Conducting a meta-analysis is crucial in discerning the true efficacy and reliability of MTAP as a surrogate marker for CDKN2A HD.
Authors
- Pavel S. Pichardo‐Rojas (ORCID: https://orcid.org/0000-0002-0804-2825)
- Luis A Marín-Castañeda (ORCID: https://orcid.org/0000-0002-1188-9795)
- Diego Pichardo-Rojas (ORCID: https://orcid.org/0009-0003-4234-2199)
- Luis Mora
- Abril Carrillo
Institutions
- Universidad de Guadalajara (MX)
- Universidad Mexicana (MX)
- Instituto Nacional de Neurología y Neurocirugía (MX)
- The University of Texas Southwestern Medical Center (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000212425
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00